SomnoMed Limited (SOMNF PINK) stock market data APIs
$0.4432
0(0%)
as of September 12, 2025
Try our APIs with
free plan!
SomnoMed Limited Financial Data Overview
Price chart is built with
Anychart
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Prev. Close
0.4432
Open
0.4432
High
0.4432
Low
0.4432
52 wk Range
0.1653-0.4848
Market Cap
109 M
Shares Outstanding
218 M
Revenue
111 M
EPS
-0.008
Beta
0.922
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SomnoMed Limited data using free add-ons & libraries
Get SomnoMed Limited Fundamental Data
SomnoMed Limited Fundamental data includes:
- Net Revenue: 111 M
- EBITDA: 1 583 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SomnoMed Limited News
New
Discovering ASX Penny Stocks: Baby Bunting Group Among 3 Noteworthy Picks
The ASX200 has experienced a volatile week, with IT, Discretionary, and Health Care sectors performing well while Materials and Energy faced challenges. Despite these fluctuations, investors continue ...
Revenues Working Against SomnoMed Limited's (ASX:SOM) Share Price
SomnoMed Limited's (ASX:SOM) price-to-sales (or "P/S") ratio of 1x might make it look like a strong buy right now compared to the Medical Equipment industry in Australia, where around half of the comp...
The past five years for SomnoMed (ASX:SOM) investors has not been profitable
Generally speaking long term investing is the way to go. But that doesn't mean long term investors can avoid big losses. For example the SomnoMed Limited (ASX:SOM) share price dropped 60% over five ye...
Shareholders May Not Be So Generous With SomnoMed Limited's (ASX:SOM) CEO Compensation And Here's Why
In the past three years, the share price of SomnoMed Limited (ASX:SOM) has struggled to grow and now shareholders are sitting on a loss. In addition, the company's per-share earnings growth is not loo...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
